Edwards Pradenas

1.3k total citations
19 papers, 222 citations indexed

About

Edwards Pradenas is a scholar working on Infectious Diseases, Genetics and Molecular Biology. According to data from OpenAlex, Edwards Pradenas has authored 19 papers receiving a total of 222 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 3 papers in Genetics and 2 papers in Molecular Biology. Recurrent topics in Edwards Pradenas's work include SARS-CoV-2 and COVID-19 Research (17 papers), COVID-19 Clinical Research Studies (10 papers) and SARS-CoV-2 detection and testing (7 papers). Edwards Pradenas is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (17 papers), COVID-19 Clinical Research Studies (10 papers) and SARS-CoV-2 detection and testing (7 papers). Edwards Pradenas collaborates with scholars based in Spain, United States and Mozambique. Edwards Pradenas's co-authors include Julià Blanco, Bonaventura Clotet, Nuria Izquierdo‐Useros, Jorge Carrillo, Carlos Ávila‐Nieto, Benjamin Trinité, Vanessa Blanc, Rubén León, Dàlia Raϊch‐Regué and Daniel Perez‐Zsolt and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Edwards Pradenas

16 papers receiving 216 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edwards Pradenas Spain 7 182 38 36 28 22 19 222
Raquel A. Binder United States 7 132 0.7× 4 0.1× 22 0.6× 9 0.3× 26 1.2× 13 199
Haya Altawalah Kuwait 9 146 0.8× 12 0.3× 8 0.2× 29 1.0× 33 1.5× 23 208
Garrick K. Yip Hong Kong 3 270 1.5× 2 0.1× 38 1.1× 32 1.1× 50 2.3× 4 307
Miyoko Hayakawa Japan 8 280 1.5× 4 0.1× 14 0.4× 35 1.3× 61 2.8× 12 321
Serena Messali Italy 7 131 0.7× 2 0.1× 12 0.3× 7 0.3× 43 2.0× 20 173
Yujing Fan Hong Kong 7 181 1.0× 2 0.1× 23 0.6× 9 0.3× 56 2.5× 13 266
Camila Pereira Soares Brazil 8 148 0.8× 4 0.1× 4 0.1× 8 0.3× 19 0.9× 16 207
Monica Tallarita Italy 5 127 0.7× 3 0.1× 10 0.3× 17 0.6× 20 0.9× 6 164
Dawit Hailu Alemayehu Ethiopia 8 72 0.4× 6 0.2× 7 0.2× 19 0.7× 32 1.5× 35 168
Laura Thümmler Germany 8 254 1.4× 2 0.1× 25 0.7× 6 0.2× 26 1.2× 16 293

Countries citing papers authored by Edwards Pradenas

Since Specialization
Citations

This map shows the geographic impact of Edwards Pradenas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwards Pradenas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwards Pradenas more than expected).

Fields of papers citing papers by Edwards Pradenas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edwards Pradenas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwards Pradenas. The network helps show where Edwards Pradenas may publish in the future.

Co-authorship network of co-authors of Edwards Pradenas

This figure shows the co-authorship network connecting the top 25 collaborators of Edwards Pradenas. A scholar is included among the top collaborators of Edwards Pradenas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edwards Pradenas. Edwards Pradenas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Alemany, Andrea, Edwards Pradenas, Ruth Aguilar, et al.. (2025). Patient and donor antibody profiles in early COVID-19 convalescent plasma therapy in the COnV-ert trial. Frontiers in Immunology. 16. 1647488–1647488.
2.
3.
Ramírez‐Morros, Anna, Alfons Jiménez, Marta Vidal, et al.. (2025). Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection. Communications Medicine. 5(1). 243–243.
4.
Tarrés-Freixas, Ferran, Eva Riveira‐Muñoz, Dàlia Raϊch‐Regué, et al.. (2025). A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model. mBio. 16(5). e0072025–e0072025. 3 indexed citations
5.
Pradenas, Edwards, Víctor Urrea, Sílvia Marfil, et al.. (2025). Recurrent waning of anti-SARS-CoV-2 neutralizing antibodies despite multiple antigen encounters. Journal of Translational Medicine. 23(1). 783–783. 2 indexed citations
6.
Roca-Ho, Heleia, Aïda Falgàs, Europa Azucena González‐Navarro, et al.. (2024). NSGS mice humanized with cord blood mononuclear cells show sustained and functional myeloid–lymphoid representation with limited graft-versus-host disease. Journal for ImmunoTherapy of Cancer. 12(10). e009198–e009198. 2 indexed citations
7.
Rubio, Rocío, Alexei Yavlinsky, Marina Escalera Zamudio, et al.. (2024). Initial antigen encounter determines robust T-cell immunity against SARS-CoV-2 BA.2.86 variant three years later. Journal of Infection. 90(2). 106402–106402. 2 indexed citations
8.
Belda, F. J., Ana Vivanco, Sílvia Marfil, et al.. (2023). Demonstration of Antibodies Against SARS-CoV-2, Neutralizing or Binding, in Seroconversion Panels After mRNA-1273, BNT-162b2, and Ad26.COV2.S Vaccine Administration. SHILAP Revista de lepidopterología. 17. 1 indexed citations
9.
Prenafeta, Antoni, Luis Javier González, Edwards Pradenas, et al.. (2023). Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate. Vaccine. 41(35). 5072–5078. 5 indexed citations
10.
Marfil, Sílvia, Edwards Pradenas, Rosa Valle, et al.. (2022). Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and humoral responses against different variants of concern in domestic pet animals and stray cats from North‐Eastern Spain. Transboundary and Emerging Diseases. 69(6). 3518–3529. 9 indexed citations
11.
Raϊch‐Regué, Dàlia, Jordana Muñoz‐Basagoiti, Daniel Perez‐Zsolt, et al.. (2022). Performance of SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Tests for Omicron and Other Variants of Concern. Frontiers in Microbiology. 13. 810576–810576. 14 indexed citations
12.
Calvet, Joan, Antonio Berenguer, Edwards Pradenas, et al.. (2022). Glucocorticoids’ treatment impairs the medium-term immunogenic response to SARS-CoV-2 mRNA vaccines in Systemic Lupus Erythematosus patients. Scientific Reports. 12(1). 14772–14772. 12 indexed citations
13.
Pradenas, Edwards, María Ubals, Víctor Urrea, et al.. (2022). Virological and Clinical Determinants of the Magnitude of Humoral Responses to SARS-CoV-2 in Mild-Symptomatic Individuals. Frontiers in Immunology. 13. 860215–860215. 5 indexed citations
14.
Felip, Eudald, Edwards Pradenas, Margarita Romeo, et al.. (2022). Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS‐CoV ‐2 mRNA ‐1237 vaccine in patients with solid tumors. Molecular Oncology. 17(4). 686–694. 3 indexed citations
15.
Díez, José María Soberanes, Carolina S. Romero, Maria Cristina Cruz, et al.. (2021). Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Hyperimmune Immunoglobulin Demonstrates Potent Neutralization and Antibody-Dependent Cellular Cytotoxicity and Phagocytosis Through N and S Proteins. The Journal of Infectious Diseases. 225(6). 938–946. 22 indexed citations
16.
Muñoz‐Basagoiti, Jordana, Daniel Perez‐Zsolt, Rubén León, et al.. (2021). Mouthwashes with CPC Reduce the Infectivity of SARS-CoV-2 Variants In Vitro. Journal of Dental Research. 100(11). 1265–1272. 54 indexed citations
17.
Rodon, Jordi, Edwards Pradenas, Sílvia Marfil, et al.. (2021). First Detection of SARS-CoV-2 Delta (B.1.617.2) Variant of Concern in a Dog with Clinical Signs in Spain. Viruses. 13(12). 2526–2526. 19 indexed citations
18.
Pradenas, Edwards, Benjamin Trinité, Víctor Urrea, et al.. (2021). Stable neutralizing-antibody levels 6 months after mild and severe COVID-19 episode. 29(1). 88–88.
19.
Carrillo, Jorge, Nuria Izquierdo‐Useros, Carlos Ávila‐Nieto, et al.. (2020). Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity. Biochemical and Biophysical Research Communications. 538. 187–191. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raquel A. Binder Breakdown of academic impact, for papers by Haya Altawalah Breakdown of academic impact, for papers by Garrick K. Yip Breakdown of academic impact, for papers by Miyoko Hayakawa Breakdown of academic impact, for papers by Serena Messali Breakdown of academic impact, for papers by Yujing Fan Breakdown of academic impact, for papers by Camila Pereira Soares Breakdown of academic impact, for papers by Monica Tallarita Breakdown of academic impact, for papers by Dawit Hailu Alemayehu Breakdown of academic impact, for papers by Laura Thümmler
Rankless by CCL
2026